CVE-2024-22461
Published: 13 December 2024
Summary
CVE-2024-22461 is a high-severity Improper Verification of Cryptographic Signature (CWE-347) vulnerability in Dell Recoverpoint For Virtual Machines. Its CVSS base score is 8.8 (High).
Operationally, ranked in the top 16.5% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-20005
Vulnerability details
Dell RecoverPoint for Virtual Machines 6.0.x contains an OS Command injection vulnerability. A low privileged remote attacker could potentially exploit this vulnerability by running any command as root, leading to gaining of root-level access and compromise of complete system.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Requires verification of digital signatures using organization-approved certificates before installation, directly preventing improper verification of cryptographic signatures.
Component authenticity commonly depends on cryptographic signatures; the control enforces proper verification of those signatures.
PKI certificates under an approved policy require cryptographic signature verification on issuance and validation.
Requires cryptographic signatures on authoritative data and support for verifying the chain of trust.
Mandates verification of cryptographic signatures (e.g., DNSSEC RRSIG) on resolution responses, addressing missing or bypassed signature checks.
Platform-independent apps typically execute inside a managed runtime or sandbox that restricts direct OS command execution, reducing the ability to exploit OS command injection.
Validates inputs to block special elements that would alter OS command execution.
Integrity tools commonly rely on cryptographic signatures whose improper validation this weakness covers.